Mortality risk in COVID-19 patients with HIV-comorbidity: meta-analysis
Journal of Epidemiology and Public Health
; 7(4):431-440, 2022.
Article
in English
| CAB Abstracts | ID: covidwho-2305217
ABSTRACT
Background:
Coronavirus disease 2019 or known as COVID-19 is a disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). Comorbidities that are risk factors for COVID-19 death include hypertension, diabetes, heart disease, COPD, HIV (Human Immunodeficiency Virus), kidney failure, and cancer. This study aims to estimate the magnitude of the risk of death in COVID-19 patients with comorbid HIV, with a meta-analysis of the primary studies conducted by the previous authors. Subjects andMethod:
This study is a systematic review and meta-analysis with the following PICO, population COVID-19 patients. Intervention HIV comorbidity. Comparison without co-morbid HIV.Outcome:
Mortality. The articles used in this study were obtained from four databases, namely PubMed, Google Scholar, Springerlink, and Science direct, using the search keys "HIV/AIDS" AND "Mortality" OR "death" AND "COVID-19 OR SARS-CoV-2. The included article is a full-text English language with a cohort study design from 2020 to 2021 and reports the adjusted Odds Ratio (aOR) in a multivariate analysis. Article selection is done by using PRISMA flow diagram. Articles were analyzed using the Review Manager 5.3 application.Results:
A total of 9 cohort studies involving 3,397,186 COVID-19 patients from America, Europe, and Africa were selected for a systematic review and meta-analysis. The data collected showed that COVID-19 patients with HIV comorbidities had a mortality risk of 3.30 times compared to COVID-19 patients without HIV comorbidities (aOR = 3.30;95% CI = 2.87 to 3.81;p<0.001).Conclusion:
HIV increases mortality risk in COVID-19 patients.
Prion; Viral; Bacterial and Fungal Pathogens of Humans [VV210]; Non-communicable Human Diseases and Injuries [VV600]; comorbidity; coronavirus disease 2019; HIV infections; human diseases; human immunodeficiency viruses; lungs; meta-analysis; mortality; pandemics; people living with HIV; respiratory diseases; risk factors; systematic reviews; viral diseases; infections; man; Severe acute respiratory syndrome coronavirus 2; Lentivirus; Africa; Europe; USA; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; APEC countries; high income countries; North America; America; OECD Countries; very high Human Development Index countries; Orthoretrovirinae; Retroviridae; RNA Reverse Transcribing Viruses; human immunodeficiency virus infections; death rate; lung diseases; SARS-CoV-2; United States of America; viral infections
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Type of study:
Prognostic study
/
Reviews
Language:
English
Journal:
Journal of Epidemiology and Public Health
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS